HILT or Conventional Combined Physical Therapy, in the Management of Hemiplegic Shoulder Pain
NCT ID: NCT06407596
Last Updated: 2024-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2022-06-01
2023-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients and methods: Participants (N = 42) were randomized into the HILT (n = 21) and TENS+US (n = 21) groups. Group 1 received 3 sessions of HILT per week for 3 weeks in addition to a therapeutic exercise program that performed 5 sessions per week for 3 weeks. Group 2 received conventional physical therapy and a therapeutic exercise program for HSP of 5 sessions per week for 3 weeks. Patients were assessed before and after treatment on the on the 6th week for radiological evaluation with ultrasonography and for clinical parameters with VAS, AMAT, MRS, and FIQ scores.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain
NCT04669405
High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain
NCT05564182
Effects of High Intensity Laser Therapy (HILT) in Patients With Subacromial Impingement Syndrome
NCT04169880
Effectiveness of High Intensity Laser Treatment In Partial Supraspinatus Tendon Tears
NCT06637410
Chronic Shoulder Pain Treatment: High Intensity Laser or Ultrasound
NCT02793401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1: high intensive laser
HILT was applied 3 times per week, totaling 9 sessions for three weeks.
high intensity laser
3 times per week, for 9 sessions
group 2: TENS+Ultrasound
tens+us used combined. 5 times per week. total 15 sessions for three weeks
tens+us
5 times per week, total 15 sessions for 3 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high intensity laser
3 times per week, for 9 sessions
tens+us
5 times per week, total 15 sessions for 3 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18,
* First-ever unilateral stroke,
* Visual analog scale (VAS) ≥30 mm,
* Time since stroke ≥6 months,
* Time since last local intervention treatment \>6 months.
Exclusion Criteria
* An unstable medical condition or uncontrolled systemic diseases (such as respiratory failure, congestive heart failure, liver and kidney dysfunction, or any other disorders affecting neuromuscular function);
* Bilateral hemiplegia;
* Cardiac pacemakers;
* Disturbance of awareness, severe visual and cognitive impairment, Mini-Mental State Examination score: \<23 points
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara City Hospital
Ankara, Çankaya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
is E2-22-1902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.